E pluribus unum

Purchasers and Lessees of certain Hino trucks may qualify for a payment in a $237.5 million class action settlement

Retrieved on: 
Friday, December 15, 2023
Defendant, Marder (infantry fighting vehicle), Extended warranty, Plaintiff, Notice, ARE, Risk, HOW, Hino Motors, E pluribus unum, Person, Settlement, PO, Hearing, Court, Insurance, Pharmaceutical industry

The Settlement Class consists of all persons or entities that purchased or leased a Settlement Class Truck through October 30, 2023.

Key Points: 
  • The Settlement Class consists of all persons or entities that purchased or leased a Settlement Class Truck through October 30, 2023.
  • If approved, the Settlement will provide compensation and other valuable benefits to Settlement Class Members.
  • After deducting Settlement Class Counsel Attorneys' Fees and Costs and Settlement Administration Costs, the remaining Settlement Cash Value will be allocated evenly, on a per-capita basis, among all Settlement Class Trucks for which the Settlement Administrator has received a valid Settlement Claim.
  • Settlement Class Counsel will ask the Court to award up to 33.33% of the Settlement Cash Value (i.e.

Roivios® announces final patient enrollment in feasibility trial for JuxtaFlow® Renal Assist Device (RAD)

Retrieved on: 
Monday, December 4, 2023
Sale, Disease, LJ, AKI, Risk, Surgeon, Mortality, Patient, RAD, Research, URPL, Acute kidney injury, Kidney, Geography, Survival, Doctor of Philosophy, Hospital, Percutaneous coronary intervention, Medical device, Nursing, E pluribus unum

"When we began this feasibility trial, we anticipated the use of the JuxtaFlow RAD to be an exciting moment," said Prof. Petrovic.

Key Points: 
  • "When we began this feasibility trial, we anticipated the use of the JuxtaFlow RAD to be an exciting moment," said Prof. Petrovic.
  • Cardiac surgery-associated AKI (CSA-AKI) occurs in up to 73% of patients who have pre-existing renal insufficiency documented as part of their standard pre-surgical workup1.
  • The JuxtaFlow RAD is used in the hospital setting and is designed to enable the kidneys to function optimally and thereby improve overall patient outcomes.
  • The BIPASS-AKI feasibility trial was being conducted pursuant to the regulations of both ALIMS in Serbia and URPL in Poland.

WARRANT HOLDERS WIN $51 MILLION IN SUIT AGAINST GETTY IMAGES FOR INTERFERENCE WITH THE EXERCISE OF THEIR WARRANTS

Retrieved on: 
Tuesday, October 31, 2023
NYSE, BVI, Getty Images, E pluribus unum, Exercise, District court, Crowell, Douglas v. U.S. District Court ex rel Talk America, Getty, Security (finance)

NEW YORK, Oct. 31, 2023 /PRNewswire/ -- On February 8, 2023, Rakower Law PLLC, as lead counsel, commenced an action with Crowell & Moring LLP against Getty Images Holdings, Inc. ("Getty Images" or the "Company") (NYSE: GETY) on behalf of two substantial holders of Getty Images' public warrants.

Key Points: 
  • NEW YORK, Oct. 31, 2023 /PRNewswire/ -- On February 8, 2023, Rakower Law PLLC, as lead counsel, commenced an action with Crowell & Moring LLP against Getty Images Holdings, Inc. ("Getty Images" or the "Company") (NYSE: GETY) on behalf of two substantial holders of Getty Images' public warrants.
  • The complaint alleged that Getty Images wrongly prevented plaintiffs from exercising their warrants as of August 22, 2022 based upon the false claim the warrants could not be exercised until an SEC Form S-1 resale registration statement became effective.
  • We are overjoyed to announce that on October 27, 2023, our clients won their case and were awarded $51 million plus interest due to Getty Images' breach in CRCM Institutional Master Fund (BVI) Ltd., et al.
  • Holders of Getty Images public warrants who were unable to exercise those warrants on or after August 22, 2022 are encouraged to contact Rakower Law.

Aclarion Announces Nociscan® Cost-Effectiveness Poster Presented at 45th Annual SMDM Meeting

Retrieved on: 
Tuesday, October 24, 2023
Low back pain, Health policy, National Science Foundation: Under the Microscope, Policy, CDMI, PD, Biomarker, Society for Medical Decision Making, Lumbar disc disease, Physician, E pluribus unum, Doctor of Philosophy, Department of Medicine – University of Pamplona, Pain, Research, Society, Meta-analysis, University of California, San Francisco, Monte Carlo, ASPN, Comparison, University, ACON, ICER, Algorithm, CO, International Society, Patient, DCLP, NSF, National Science Foundation, Nursing

The 45th Annual Society for Medical Decision Making (SMDM) Meeting is being held October 22-25, 2023.

Key Points: 
  • The 45th Annual Society for Medical Decision Making (SMDM) Meeting is being held October 22-25, 2023.
  • Founded in 1979, SMDM promotes scientific and methodological rigor in health care decision research and its application to health policy and clinical care.
  • “We are pleased with the compounding interest in the Nociscan cost-effectiveness research,” said Ryan Bond, Chief Strategy Officer at Aclarion.
  • In July 2023, a Nociscan cost-effectiveness poster was presented at the American Society for Pain & Neuroscience (ASPN) annual meeting.

Deadline in 3 Days for Hawaiian Electric Industries, Inc. Investors: Kessler Topaz Meltzer & Check, LLP Reminds Hawaiian Electric Industries, Inc. (HE) Investors of Filing Deadline in Class Action Lawsuit

Retrieved on: 
Friday, October 20, 2023
Insurance, NYSE, Wildfire, COPY, News, Court, E pluribus unum, Wind, Electricity, The Wall Street Journal, LLP, District court, Lead, Annual report, Fire, Private investigator, Pharmaceutical industry, Cryptocurrency, Hawaiian Electric Industries

The action charges Hawaiian Electric with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company’s business, operations, and prospects.

Key Points: 
  • The action charges Hawaiian Electric with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company’s business, operations, and prospects.
  • As a result of Hawaiian Electric’s materially misleading statements and omissions to the public, Hawaiian Electric’s investors have suffered significant losses.
  • Kessler Topaz Meltzer & Check, LLP encourages Hawaiian investors who have suffered significant losses to contact the firm directly to acquire more information.
  • The class action complaint against Hawaiian Electric, Bhangal v. Hawaiian Electric Industries, Inc., et al., Case No.

ImmunityBio Announces Biological License Application Resubmission for N-803 in BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer Carcinoma-In-Situ

Retrieved on: 
Monday, October 23, 2023
Biotechnology, Health, Pharmaceutical, Clinical Trials, Oncology, CR, Survival, CIS, FDA, Patient, Bladder cancer, Food, E pluribus unum, Treatment, Vol, Safety, The New England Journal of Medicine, Pivotal trial, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Maintenance, Literature, Immune system, NK, Massachusetts Medical Society, NEJM, Probability, Case series, PMID, Cystectomy, BCG, NMIBC, BLA, Exception, Vaccine, ImmunityBio COVID-19 vaccine, Tolerability

The BLA is supported by the results of ImmunityBio’s studies in bladder cancer including the pivotal QUILT-3.032 study (NCT03022825), published in NEJM Evidence1 in November 2022.

Key Points: 
  • The BLA is supported by the results of ImmunityBio’s studies in bladder cancer including the pivotal QUILT-3.032 study (NCT03022825), published in NEJM Evidence1 in November 2022.
  • Of the nine subjects, two were deceased from causes other than bladder cancer and one was lost to follow-up.
  • Final clinical Results of Pivotal Trial of IL-15rαfc Superagonist N-803 with BCG in BCG-Unresponsive CIS and Papillary Non-Muscle Invasive Bladder Cancer (NMIBC).
  • Phase II/III Clinical Results of IL-15rαfc Superagonist N-803 with BCG in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC) Carcinoma in Situ (CIS) Patients.

Kognic Unveils The Alignment Platform™, Enabling Businesses to Accelerate AI Product Development

Retrieved on: 
Tuesday, October 17, 2023
Pressure, Lidar, Perception, Machine learning, Yoy, AI, Ninja, Engineering, Data, Safety, Alignment, Trust, Entrepreneurship, E pluribus unum, Robotics, McKinsey & Company, Radar, Architecture, MLOps, Silicon, CFO, Research, Medical device

SANTA CLARA, Calif., Oct. 17, 2023 /PRNewswire-PRWeb/ -- Kognic, industry leader in machine learning tools for safety-critical AI, launches The Alignment Platform™, a new offering that will allow AI businesses to accelerate their product development and ensure AI systems are trusted and safe.

Key Points: 
  • SANTA CLARA, Calif., Oct. 17, 2023 /PRNewswire-PRWeb/ -- Kognic , industry leader in machine learning tools for safety-critical AI, launches The Alignment Platform™, a new offering that will allow AI businesses to accelerate their product development and ensure AI systems are trusted and safe.
  • As AI adoption and development continues to advance, McKinsey's latest research reveals that models and tools are the biggest challenge for high-performing AI businesses.
  • Kognic's AI Alignment Platform™ fills this critical gap in the market, defining, refining and validating large datasets to train machine learning models.
  • As AI continues to develop at a rapid rate, the volume of data AI developers and businesses manage will explode.

Kognic unveils The Alignment Platform™, enabling businesses to accelerate AI product development and ensure AI systems are trusted and safe

Retrieved on: 
Tuesday, October 17, 2023
Pressure, Lidar, Perception, Machine learning, Yoy, Bosch, AI, Ninja, Engineering, Data, Safety, Continental, Alignment, Trust, Entrepreneurship, E pluribus unum, Robotics, McKinsey & Company, Radar, Architecture, MLOps, Silicon, CFO, Research, Smart Eye, Sales, Medical device, Qualcomm

GOTHENBURG, Sweden, Oct. 17, 2023 /PRNewswire/ -- Kognic , industry leader in machine learning tools for safety-critical AI, launches The Alignment Platform™, a new offering that will allow AI businesses to accelerate their product development and ensure AI systems are trusted and safe.

Key Points: 
  • GOTHENBURG, Sweden, Oct. 17, 2023 /PRNewswire/ -- Kognic , industry leader in machine learning tools for safety-critical AI, launches The Alignment Platform™, a new offering that will allow AI businesses to accelerate their product development and ensure AI systems are trusted and safe.
  • As AI adoption and development continues to advance, McKinsey's latest research reveals that models and tools are the biggest challenge for high-performing AI businesses.
  • Kognic's AI Alignment Platform™ fills this critical gap in the market, defining, refining and validating large datasets to train machine learning models.
  • As AI continues to develop at a rapid rate, the volume of data AI developers and businesses manage will explode.

Attention HE Shareholders: Kessler Topaz Meltzer & Check, LLP Reminds Shareholders of Securities Fraud Class Action Lawsuit Filed against Hawaiian Electric Industries, Inc. (HE) and Encourages Investors to Contact the Firm

Retrieved on: 
Thursday, October 12, 2023
NYSE, Fire, The Wall Street Journal, LLP, Wildfire, Wind, Lead, Court, Insurance, District court, Electricity, E pluribus unum, Annual report, News, COPY, Private investigator, Pharmaceutical industry, Cryptocurrency, Hawaiian Electric Industries

The action charges Hawaiian Electric with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company’s business, operations, and prospects.

Key Points: 
  • The action charges Hawaiian Electric with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company’s business, operations, and prospects.
  • As a result of Hawaiian Electric’s materially misleading statements and omissions to the public, Hawaiian Electric’s investors have suffered significant losses.
  • Kessler Topaz Meltzer & Check, LLP encourages Hawaiian investors who have suffered significant losses to contact the firm directly to acquire more information.
  • The class action complaint against Hawaiian Electric, Bhangal v. Hawaiian Electric Industries, Inc., et al., Case No.

Twenty Years of the NuVasive XLIF Procedure Celebrated at the Society for Minimally Invasive Spine Surgery 2023 Annual Forum

Retrieved on: 
Tuesday, October 10, 2023
Diagnosis, Neoplasm, Partnership, NYSE, Health care, MIS, Economics, Standard of care, Comparison, Globus Medical, Safety, Health, Rush University Medical Center, Spine, Patient, E pluribus unum, Society, Education, Deformity, Trauma, Surgeon, NuVasive, Risk management, Ayaka Miyauchi, Research, Dentistry, Bookbinding, Hospital, Silviculture

AUDUBON, Pa., Oct. 10, 2023 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, celebrated twenty years of the NuVasive XLIF procedure at the Society for Minimally Invasive Spine Surgery (SMISS) ’23 Annual Forum.

Key Points: 
  • AUDUBON, Pa., Oct. 10, 2023 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, celebrated twenty years of the NuVasive XLIF procedure at the Society for Minimally Invasive Spine Surgery (SMISS) ’23 Annual Forum.
  • “Very few medical technology innovations have transformed an industry like the NuVasive XLIF procedure.
  • Hosted by NuVasive, the evening event featured more than 20 surgeon speakers discussing the past, present and future impact of the procedure.
  • Economics of less invasive spinal surgery: an analysis of hospital cost differences between open and minimally invasive instrumented spinal fusion procedures during the perioperative period.